ORIC Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for ORIC Pharmaceuticals, Inc. (ORIC) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents59.4123.3866.84236.98293.60
Short-Term Investments196.55184.80139.4310.97215.15
Cash & Short-Term Investments255.96208.19206.27236.98293.60
Accounts Receivable0.000.000.000.000.00
Inventory0.000.000.000.000.00
Other Current Assets6.294.414.191.600.80
Total Current Assets262.25212.60210.46240.52296.70
Non-Current Assets
Property, Plant & Equipment (Net)2.9212.0114.242.411.98
Long-Term Investments0.0026.8521.9543.390.00
Other Non-Current Assets8.970.550.5312.320.32
Total Non-Current Assets11.8939.4136.7258.122.30
Total Assets274.14252.01247.18298.64299.00
Current Liabilities
Accounts Payable1.550.941.3215.159.00
Short-Term Debt3.180.000.000.000.00
Accrued Liabilities20.1216.7611.4111.347.70
Other Current Liabilities20.120.000.000.000.55
Total Current Liabilities24.8520.4615.3915.159.00
Non-Current Liabilities
Long-Term Debt0.000.000.000.000.00
Other Non-Current Liabilities6.177.469.4410.520.22
Total Non-Current Liabilities6.177.469.4410.520.22
Total Liabilities31.0227.9224.8325.679.22
Stockholders' Equity
Common Stock0.010.010.010.000.00
Retained Earnings-562.77-434.93-334.23-245.21-166.42
Accumulated Other Comprehensive Income0.380.26-1.29-0.10-0.03
Additional Paid-in Capital805.51658.75557.87518.18456.20
Shares Outstanding71.0254.8745.0939.430.00
Total Stockholders' Equity243.12224.09222.35272.98289.78
Total Liabilities & Equity274.14252.01247.18298.64299.00